The evidence for a role of vasospasm in the pathogenesis of cerebral malaria
© Eisenhut. 2015
Received: 11 August 2015
Accepted: 1 October 2015
Published: 13 October 2015
Due to delay in treatment, cerebral malaria (CM) remains a significant complication of Plasmodium falciparum infection and is a common cause of death from malaria. In addition, more than 10 % of children surviving CM have neurological and long-term cognitive deficits. Understanding the pathogenesis of CM enables design of supportive treatment, reducing neurological morbidity and mortality. Vaso-occlusion and brain swelling appear to be leading to clinical features, neuronal damage and death in CM. It is proposed that parasitized red blood cells (pRBC), due to cytoadhesion to the endothelium and vasospasm induced by reduced bioavailability of nitric oxide, are causes. Stasis of blood flow and accumulation of pRBC may allow, after schizont rupture, for high concentration of products of haemolysis to accumulate, which leads to localized nitric oxide depletion, inducing adhesion molecules and cerebral vasospasm. Features consistent with an involvement of vasospasm are rapid reversibility of neurological symptoms, intermittently increased or absent flow in medium cerebral artery detectable on Doppler ultrasound and hemispheric reversible changes on cerebral magnetic resonance imaging in some patients. Clinical trials of treatment that can rapidly reduce cerebral vasospasm, including nitric oxide donors, inhaled nitric oxide, endothelin or calcium antagonists, or tissue plasminogen activators, are warranted.
A significant proportion of the 584,000 (95 % uncertainty interval, 367,000–755,000) malaria deaths in 2013  were due to cerebral malaria (CM). The majority of affected children were living in sub-Saharan Africa and were under 5 years old. For clinical purposes, CM has been defined by the WHO as an encephalopathy, where asexual Plasmodium falciparum parasitaemia is detectable in peripheral blood and without an alternative cause. Even with optimal care CM was reported to have a mortality of 15–25 % in children and 20 % in adults [2, 3]. Fifty to 75 % of deaths were found to occur within 24 h of admission to hospital . This means any supportive treatment aimed at reducing mortality in CM has to be able to rapidly reverse key pathophysiological events leading to CM. Targeting inflammatory cascades or the sequestered parasites, which have been associated with the pathogenesis of CM, may take effect with a delay of days. Targeting the end result of brain swelling, which is linked to mortality  by osmotic therapy, has not been successful . There is, therefore, an urgent need to identify rapidly reversible mechanisms of CM.
Mouse models have been used to investigate potential treatments for human CM. The cerebral pathology in the mouse model of CM (experimental cerebral malaria (ECM)) is fundamentally different from human CM in the sense that in Plasmodium berghei (ANKA strain) infection of C57BL/6 or CBA mice, the CM is characterized by sequestration of leukocytes in the brain, while in human CM mainly parasitized red blood cells (pRBC) are sequestered. Conclusions drawn from findings in this model may not apply to humans . Mice depleted of lymphocytes do not develop white cell sequestration in the brain. Vasospasm has, on the basis of histopathological findings, first been proposed to be involved in human CM by Polder et al.  and would be accessible to treatment successfully applied in other diseases associated with cerebral vasospasm, such as sub-arachnoid haemorrhage. This review had the objective to identify and summarize features of cerebral vasospasm in previous studies of human CM and explore how these findings could be used to lay the foundations of therapeutic approaches.
Key features of cerebral malaria
Neurological features of acute CM and long-term neurological deficits were comprehensively reviewed previously . Following the WHO definition, an essential feature of CM is coma with the inability to localize painful stimuli. Investigation of brain activity during coma revealed bilateral slowing on electroencephalography. Seizures may occur in up to 60 % of hospitalized children. Seizures are less common in adults where they occur in 20 %. There may be brainstem signs, including abnormal eye movements, changes in pupillary size and reaction, absence of corneal and oculocephalic reflexes, disorders of conjugate gaze and abnormal breathing patterns, abnormal posture, and abnormalities of tone and reflexes. Such signs are more common in children than in adults. Recovery of consciousness occurs usually within 48 h. Features of poor prognosis for survival and long-term morbidity were deep coma, multiple and prolonged seizures and absent corneal and oculocephalic reflexes. Elevated lactate levels in plasma and cerebrospinal fluid were linked to increased mortality.
Electroencephalography during seizures showed that the origin of seizures was often the temporo-parietal region (a watershed area). The review authors suggested that this may indicate that ischaemia and hypoxia are involved in its aetiology.
Neurological deficits in survivors of cerebral malaria
Neurological deficits in children with CM summarized from previous studies  were identifiable in 11 % and include hemiparesis (4.4 %), quadriparesis (3.5 %), ataxia (2.5 %), visual (2.3 %) and speech (2.1 %) impairments, hearing loss (1.9 %) and behavioural difficulties (1.3 %).
In adults neurological deficits as sequelae were observed in less than 5 % and characteristically included extrapyramidal tremor and other cerebellar signs, cranial nerve palsies, mononeuritis multiplex, and polyneuropathy . In the majority of survivors of CM neurological deficits were reversible.
The result of imaging studies
In a recent study, magnetic resonance imaging (MRI) was performed in 38 paediatric survivors of CM. Abnormalities found were focal cortical defects (16 %), sub-cortical T2 signal changes (18 %), atrophy (47 %), and periventricular T2 signal changes (53 %). Acute papilloedema occurred in patients with sub-cortical T2 signal changes. Periventricular T2 signal changes were found in patients with peripheral retinal whitening .
A large, detailed MRI study on 152 children with CM was conducted in Malawi and compared findings in retinopathy-positive and -negative patients; MRI features, which were more common in children with retinopathy were brain swelling, basal ganglia involvement, cortical abnormalities on T2, periventricular white matter changes, brainstem abnormalities on T2, thalamic involvement and corpus callosum changes on T2 and diffusion-weighted images, as well as cerebellar changes. In children with retinopathy-positive CM, it is important to note that some had unilateral hemispheric predominance of oedema, predominance in the globus pallidus and cortical involvement was noted to be “occasionally markedly asymmetrical hemispheric” . In a case of CM reported by another group, single photon emission computed tomography was performed. Focal right hemispheric hypoperfusion was found, which correlated to the patient’s right hemispheric localizing signs. Transcranial dopper sonography however was normal in this patient. Neurological symptoms and abnormalities on imaging subsequently completely resolved . Features of brain swelling were found to be more common in children with CM compared to adults and more common in children, who died of CM . Brain swelling may explain that brainstem signs and papilloedema are more common in children [4, 11].
In vivo studies of angiopathy in cerebral malaria
Retinal changes on fundoscopy and fundus fluorescein angiography
Recent in vivo studies on retinas in 34 Malawian children with CM by fluorescein angiography showed zones of capillary non-perfusion in 76 % of patients, involving the macula in 56 % and the retinal periphery in 65 %, indicating the presence of obstructed retinal capillaries and postcapillary venules. The blood vessels affected were matched by retinal whitening in fundal photography. In 26 % of patients, angiography showed large occluded vessels with resulting ischemic areas in the supplied peripheral retina downstream. There were vessels with abrupt pruning of larger arterioles with normal perfusion right up to the point of non-perfusion. Normal angiograms in six patients, including two with neurological sequelae, indicated a lack of long-standing vaso-occlusion .
An observational study was performed in 42 adults with falciparum malaria, of which 27 patients were suffering from complicated malaria. The study used bedside, portable, high-resolution, digital retinal photography and compared patients with complicated and uncomplicated falciparum malaria.
Malarial retinopathy was present in 63 % of adults with severe malaria, in 70 % with CM and in 43 % with non-cerebral severe malaria. The severity of retinal findings correlated with disease severity. Admission blood lactate levels correlated significantly with the severity of retinal and macular whitening in patients with severe malaria. Haematocrit on admission correlated negatively with the quantity of white-centred haemorrhages. The severity of retinal haemorrhages correlated with anaemia. Differences between retinopathy in adults and children evident from this study were that blood vessel discolouration detected in about 30 % of children with CM was not found in any of the adults. The vessel discolouration was compatible with depletion of stationary RBCs infected with mature parasites of haemoglobin.
Retinal whitening and discolouration of retinal blood vessels, but not retinal haemorrhages, were associated with occluded blood vessels on fluorescein angiography .
Changes of vascular tone
Peripheral arterial tonometry measures the change in digital pulse wave amplitude in reaction to hyperaemia resulting in a reactive hyperaemia peripheral arterial tonometry (RH-PAT) index, which provides a measurement of reactive vasodilation. The arterial pulsatile volume is measured in the index finger at rest and compared with that obtained after an increase induced by 5 min of forearm ischemia (sphygmomanometer inflated to 200 mmHg) and with values obtained in the contralateral index finger without reactive hyperaemia. It is known that the RH-PAT index is partially (≤50 %) reflecting endothelial nitric oxide (NO) production.
Patients with severe malaria had a significantly reduced RH-PAT index in the peripheral circulation compared to uninfected controls or patients with uncomplicated malaria .
In another study using RH-PAT, patients with severe malaria had a significantly lower RH-PAT index and cell-free haemoglobin, and plasma arginase levels were inversely correlated to RH-PAT indexes. In patients who survived >24 h after enrolment, there were significant associations between increase in RH-PAT index and both decreasing cell-free haemoglobin and increasing l-arginine concentrations .
Changes of blood flow on cerebral Doppler studies
Cerebral vasospasm has been defined by Lindegaard using blood velocity measurements by transcranial Doppler ultrasounds. He found that a narrowing of vessel diameter on angiography is associated with increased velocity with a ratio of >3 in middle cerebral artery to extracranial internal carotid artery flow diagnostic of vasospasm .
In a pioneering study, Newton et al. investigated cerebral haemodynamics by transcranial Doppler . On investigation of 50 children with CM, in 30 % an increase in cerebral blood flow velocity was observed. Six of 11 children with neurological sequelae had sonographic abnormalities associated with unilateral deficits, including two children where the contralateral middle cerebral artery could not be ultrasonicated and two where seizures were associated with a transient increase in Doppler velocity. In three children, who died, ultrasonographic features of increased intracranial pressure were documented. Subsequent studies confirmed the finding of an increased blood flow velocity in CM .
The role of nitric oxide in cerebral malaria
Over recent years the role of NO in the pathogenesis of CM including reduction of pRBC sequestration and reduction of vasospasm has been increasingly recognized. NO is an endogenous vasodilator produced in endothelium by the endothelial NO synthase (eNOS) enzyme. Without the presence of RBCs NO has a half-life of up to several minutes. It can therefore diffuse across cell membranes and act as an intercellular messenger. NO diffuses from the endothelium to nearby smooth muscle. There it binds to the haem group of the guanylate cyclase. This causes this enzyme to convert guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP) and cGMP then activates cGMP-dependent protein kinases and produces vasodilatation .
NO can down-regulate transcription of endothelial adhesion molecule genes, including E-selectin, VCAM-1, ICAM-1 and P-selectin. NO increases the expression of endothelin B receptors (a receptor mediating vasodilatation) and decreases expression of endothelin-1, the most powerful endogenous vasoconstrictor .
Inhibition of NO production by exposure of human microvascular endothelial cell to the NOS inhibitor L-N(G)-nitro-arginine-methyl-ester (L-NAME) increased P. falciparum pRBC adhesion, while addition of a NO-donor reduced adhesion. In vitro studies showed that the NO donor 3-(2-hydroxy-2-nitroso-1-propylhydrazino)-1-propanamine (PPN) treatment reduced the number of adherent pRBCs on resting and TNF stimulated human microvascular endothelial cells (HMECs) by down-regulating basal ICAM-1 expression . NO effects therefore have features which may be protective against complications of P. falciparum infection by inhibition of cyto-adherence. Patients with CM were found to have decreased plasma and cerebrospinal levels of the nitric oxide metabolites nitrite and nitrate .
Patients with CM also had reduced levels of l-Arginine, the substrate for NO production by nitric oxide synthase. Hypoargininaemia was strongly associated with mortality .
The role of haemolysis in cerebral malaria
RBC arginase appears in the plasma during haemolysis and is in competition with NOS for the same substrate, l-arginine .
Direct evidence for a role of haemolysis in determining vascular tone in severe malaria in humans comes from an observational study in Indonesian adults, which demonstrated that reactive RH-PAT index was correlated with haptoglobin concentrations. Infusion of l-arginine, which is the substrate for the NO synthase producing nitric oxide, significantly increased the RH-PAT index .
Support for a role of depletion of nitric oxide by the haemolytic process in the pathogenesis of CM would be an association of elevated free haemoglobin with CM. This has recently been confirmed by comparison of free haemoglobin in children with moderately severe malaria, severe malaria and CM in Tanzania, where only children with CM had a significant elevation of plasma cell free haemoglobin compared to healthy controls .
The role of endothelins
To gather evidence for a role of vasospasm in CM it is essential to examine data on the association of vasoconstrictors with features of CM. Endothelin-1 is one of the most potent vasoconstrictors. Two studies analysing ET-1 during malaria infection in humans have been reported to date [29, 30]. They showed that ET-1 was increased in patients with complicated falciparum malaria compared to controls. There was no correlation between serum levels of ET-1 and severity of disease. Studies conducted in vitro demonstrated that lipid components of the parasite present in the membrane of P. falciparum-infected RBCs and malaria pigment (haemozoin) can both bind ET-1 . The authors speculated that non-specific binding could reduce ET-1 activity by decreasing its presence in the local microenvironment where sequestration of pRBCs occurs.
Post-mortem examination of patients who died of cerebral malaria
In landmark quantitative analyses of brain sections in post-mortem studies of patients in Thailand and Vietnam, it was demonstrated that adults with CM had more pRBCs sequestered in the brain than patients who died of other complications of malaria. In addition, pRBC sequestration in the brain of CM patients was also more pronounced compared to other organs [32, 33]. Adults and children succumbing to CM showed significantly increased expression of intercellular adhesion molecule-1 (ICAM-1) in the brain, which mediates adhesion of pRBC to the endothelium of cerebral capillaries and venules . Inflammation involving release of tumour necrosis factor has been involved in up-regulation of ICAM-1 expression in endothelial cells and the process of induction of this inflammation has been reviewed elsewhere [35, 36]. In an autopsy series on children who died of CM, 34 % were found to have no discernible cerebral histological changes, only minimal malarial pigment and very few parasites within cerebral vessels . There was no or little detectable inducible nitric oxide synthase found in cerebral endothelial cells of those patients .
The most extensive retinal histopathological examination in CM reported so far included findings of the eyes of 64 children, including 13 cases with a clinical diagnosis of CM but an alternative cause of death. All patients with systemic pathological features of CM had prominent sequestration of early or late stage parasites in the retinal vasculature. Haemorrhages were significantly more common in CM patients compared to patients with non-malarial disease. There were significantly more thrombi seen in the retinal vessels of patients with CM than in the non-CM group. Thrombi were found to often only partially occlude blood vessels and seen without surrounding haemorrhage .
In a more recent study on the same population in Malawi  in 13 children with histologically proven CM, all had malarial retinopathy and showed pRBC sequestration in a mean of 69 % of retinal capillaries and a mean of 81 % of retinal venules. The percentage of pRBC sequestration correlated significantly with the grade of malaria retinopathy severity detected before death. There was a positive correlation of percentage of capillaries with pRBC in the retina and brain. It is important to note that the presence of extra-erythrocytic haemozoin was higher in patients with moderate to severe malarial retinopathy compared to patients with mild malarial retinopathy. The authors noted vascular congestion in retinal venules which showed a high density of pRBCs, confirming a previous histopathological study conducted in Vietnam which demonstrated that congestion of heavily parasitized cerebral micro-vessels was associated with a reduction of Glasgow coma scale (GCS) during coma and shortening of time of coma before death .
Treatment of cerebral malaria
Nitric oxide donors
There has been, so far, only been one published trial in humans addressing the bioavailability of the vasodilator nitric oxide. Intravenous infusion of l-Arginine (l-Arg) was associated with an increase in the RH-PAT index and led to an increase in exhaled NO levels in patients with moderately severe malaria  and was shown to be safe [42, 43]. In a subsequent, randomized study of intravenous l-Arg infusion in Indonesian adults with severe malaria, no effect on clearance of lactate or RH-PAT index was detected . Currently, randomized controlled trials are awaiting publication , or are planned  exploring the effect of inhaled nitric oxide as adjuvant treatment of CM.
The evidence for vasospasm in cerebral malaria
This review shows that previous studies have not demonstrated direct evidence of vasospasm in human CM. Reason for this may be that studies conducted so far have not used internationally recognized criteria, such as the Lindegaard criteria of flow ratio of >3 in middle cerebral artery to extracranial internal carotid artery flow, or cut-offs for definition of significantly increased flow on Doppler ultrasound , to define vasospasm in CM. Future studies need to assess patients with this method for evidence of vasospasm. This method previously found evidence for vasospasm in bacterial meningitis where low GCS (<7) on admission, seizures and focal cerebral ischaemic deficits, were more common in patients with cerebral blood flow velocity >210 cm/s, compatible with vasospasm .
The rapid reversibility of coma and neurological deficits in the majority of patients with CM is consistent with a role of transient vasospasm and against a vascular obstruction by thrombi or sequestered pRBCs;
The unilateral asymmetrical hemispheric changes on cerebral MRI and transient hemispheric changes on single-photon emission computed tomography. described in some patients are compatible with a transient vasospasm in a large supplying artery and cannot be explained by thrombi or sequestration. Obstruction of a large artery by thrombus or sequestered pRBCs has not been found on post-mortem studies of patients who died of CM;
Transient increase in Doppler flow during seizures in CM cannot be explained by sequestration or thrombi but by vasospasm. The lack of detection of middle cerebral artery by Doppler in patients associated with transient neurological deficits is also most likely due to transient vasospasm;
Normal angiograms in six patients, including two with neurological sequelae, indicated a lack of long-standing vaso-occlusion more compatible with vasospasm than other forms of vasocclusion;
In a sub-group of patients, features of fatal CM were found without sequestration of pRBCs or thrombi in cerebral blood vessels on autopsy. The absence of inducible NO synthase (iNOS) expression in endothelial cells in these patients was against this absence of pRBCs being due to recent simultaneous bursting of sequestered pRBCs, which would have induced iNOS expression;
RH-PAT shows changes during malaria compatible with changes of nitric oxide bioavailability, which could predispose to and cause vasospasm.
Seizures, headaches, persistent neurological deficits, including aphasia, hemiplegia, hemianopia, or cortical blindness
MRI findings of sub-arachnoid and intracerebral haemorrhages, cerebral infarction, and reversible brain oedema, hyperintensities on T2 imaging involving the cortex and sub-cortical and deep white matter
Doppler ultrasonographic findings
Maximum mean flow velocities in the middle cerebral arteries might be normal during the first few days after onset of symptoms
Conditions associated with ocular vasospastic syndrome have been associated with retinal arterial vaso-occlusion and ischemia . There is a clear causal link between vasospastic conditions and secondary cerebral haemorrhages as well as evidence for vasospasm being secondary to extravasated blood. In children with CM, haemoglobin depleted retinal blood vessels (secondary to haemolysis) were associated with non-perfusion on angiography and retinal whitening  compatible with a role of haemolysis in vaso-occlusion by vasospasm.
The aetiology of brain swelling in cerebral malaria
Against a disruption of the blood brain barrier as cause of brain swelling in CM, is the fact that radioactively labelled albumin given intravenously was not found in cerebrospinal fluid during coma and no increase was found in the albumin index (ratio of concentrations of albumin in cerebrospinal fluid to those in blood) [50, 51]. Previous investigators proposed a cytotoxic aetiology of brain swelling from ischaemia . Vasospasm could be involved in such ischemia. Hypoxia in vasospasm-induced ischemia can lead to break down of the cytoskeleton which can then lead to a dysregulation of membranous ion transport, which maintains the osmotic gradient across cell membranes and cell layers, and which can prevent cellular and interstitial oedema . The rapid resolution of such oedema in survivors of CM is against a complete obstruction of blood vessels by sequestrated pRBCs or thrombi and is more compatible with a dominance of rapidly reversible vasospasm in its pathogenesis.
Another proposed explanation of brain swelling in CM is pooling of blood in congested cerebral veins from parasite sequestration. Against this hypothesis is the finding of unilateral brain abnormalities on scanning found in some patients with CM, which is unlikely to occur with the disseminated nature of parasite sequestration affecting both cerebral hemispheres.
Cerebral vasospasm is likely to be more reversible than sequestration. Resolution of vasospasm may be an essential requirement for reversal of sequestration by increasing shearing forces by increased flow through widening blood vessels. Vascular resistance is crucially dependent on diameter. The rapid reversibility of vasospasm makes it the ideal target for rapid treatment of this potentially fatal complication of falciparum malaria.
The potential of treatments of cerebral vasospasm occurring in the context of sub-arachnoid haemorrhages
To find therapeutic options for any vasospasm contributing to the pathogenesis of CM it is essential to be aware of all treatment that has been shown to reduce cerebral vasospasm rapidly in humans and has been demonstrated to be safe in randomized controlled trials. Such trials have been conducted in patients with cerebral vasospasm associated with sub-arachnoid haemorrhages. A similar mechanism to sub-arachnoid haemorrhage-associated vasospasm caused by haemolysis of extravasated RBCs in the sub-arachnoid space may mediate vasospasm through depletion of nitric oxide and induction of endothelin-1 release in CM because of schizont rupture-related haemolysis as well as the breakdown of extravasated blood from the frequently encountered intracerebral microhaemorrhages associated with more severe disease. Treatments that were found to rapidly reverse cerebral vasospasm in sub-arachnoid haemorrhage and have been summarized previously  include calcium channel blockers, such as nimodipine or nicardipine, which reduced the risk of poor outcome (dependency, vegetative state or death) and secondary ischemia [54, 55], endothelin receptor antagonists, which reduced the incidence of delayed ischemic neurological deficit (DIND) and angiographic vasospasm [56, 57], and intra-thecal tissue plasminogen activator, which was associated with significant reductions in poor outcomes, DINDs and angiographic vasospasm .
The relevance of erythropoietin in CM was demonstrated by the fact that high levels of erythropoietin (EPO) were measured in African children with severe malarial anaemia and were associated with a 80 % reduction in the risk of neurological sequelae during CM . EPO is found in the cerebrospinal fluid only after very high intravenous doses, which can have systemic, including haematopoietic, adverse effects.
It has recently been described that the non-haematopoietic and haematopoietic functions of EPO are transmitted through different receptors. To reduce side effects of EPO, non-haematopoietic EPO derivatives have been generated, such as asialoEpo and carbamylated Epo (CEPO), that maintain their tissue-protective activities but do not increase the concentration of RBCs . EPO has been used to reduce vasospasm in sub-arachnoid haemorrhage in a randomized controlled trial, which was associated with reduced DIND with new cerebral infarcts, a reduction of impaired auto-regulation and better outcome at discharge . There is a need for randomized controlled trials using non-haematopoietic EPO derivatives in treatment of CM.
Reducing adverse effects of haemolysis
Future research needs to find supportive evidence for the role of haemolysis in CM. This can be gained indirectly by investigating the role of the HO-1 in CM: ferritin, bilirubin and iron could be measured in the cerebrospinal fluid of patients with CM compared to controls with uncomplicated and complicated falciparum malaria, as they are end-products of haem metabolism by HO-1 .
Prevention of the effect of free haemoglobin in reducing nitric oxide bioavailability has been achieved by use of haptoglobin . Capturing the nitric oxide scavenging haem group remaining unbound in malaria-induced haemolysis has been achieved by haemopexin (Hx) in other diseases associated with haemolysis .
Inhaled nitric oxide
Inhaled nitric oxide (iNO) could be particularly useful as supportive treatment of CM: unlike nitric oxide donors, such as nitroglycerine and sildenafil, iNO has not been associated with anaemia or systemic vasodilatation causing hypotension. Unlike NO donors, for iNO there is no requirement for a functional endothelial cell NO synthase (eNOS). eNOS may be dysfunctional in some patients. NO gas manufacture is affordable, and can be administered by mask without significant infrastructure requirements  and Hawkes et al. are currently exploring its effectiveness in reducing morbidity and mortality in a trial in patients with CM. In addition to developing application of iNO, once effective doses of the phosphodiesterase inhibitor-5 sildenafil, l-arginine, nitrite or nitroglycerin for reducing cerebral vasospasm are established, side effects could be minimized by using combinations of these agents, potentially enabling dose reductions of the individual agent.
CM remains a significant clinical problem associated with delayed recognition and treatment of falciparum malaria in endemic areas. CM is associated with significant mortality occurring rapidly after admission to hospital. Survival of CM can be associated with permanent neurological and neurocognitive deficits. The key events in the pathophysiology of CM may be vaso-occlusion by sequestration of pRBCs and vasospasm. Haemolysis resulting from rupture of adherent schizonts may cause depletion of nitric oxide by binding of nitric oxide to free haem released by this haemolytic process. Nitric oxide depletion causes vasospasm and increases pRBC adhesion by up-regulation of intercellular adhesion molecule-1 expression. Strategies relieving cerebral vasospasm are most likely to rapidly reverse coma and reduce the risk of ischemic neurological deficit in CM.
The author declares there is no financial or competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO: World Malaria Report 2014. Geneva: World Health Organization. http://www.who.int/malaria/publications/world_malaria_report_2014/en/.
- Seydel KB, Kampondeni SD, Valim C, Potchen MJ, Milner DA, Muwalo FW, et al. Brain swelling and death in children with cerebral malaria. NEJM. 2015;372:1126–37.PubMed CentralView ArticlePubMedGoogle Scholar
- WHO. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94(suppl 1):1–90.Google Scholar
- Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:827–40.View ArticlePubMedGoogle Scholar
- Okoromah CAN, Afolabi BB, Wall ECB. Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria. Cochrane Database Syst Rev. 2011. doi:10.1002/14651858.CD004615.pub3.PubMed CentralPubMedGoogle Scholar
- White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. The murine cerebral malaria phenomenon. Trends Parasitol. 2010;26:11–5.PubMed CentralView ArticlePubMedGoogle Scholar
- Polder TW, Jerusalem CR, Eling WMC. Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci. 1991;101:35–46.View ArticlePubMedGoogle Scholar
- Kampondeni SD, Potchen MJ, Beare NAV, Seydel KB, Glover SJ, Taylor TE, et al. MRI findings in a cohort of brain injured survivors of pediatric cerebral malaria. Am J Trop Med Hyg. 2013;88:542–6.PubMed CentralView ArticlePubMedGoogle Scholar
- Potchen MJ, Kampondeni SD, Seydel KB, Birbeck GL, Hammond CA, Bradley WG, et al. Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. Am J Neuroradiol. 2012;33:1740–6.PubMed CentralView ArticlePubMedGoogle Scholar
- Kampfl A, Pfausler B, Haring HP, Denchev D, Donnemiller E, Schmutzhard E. Impaired microcirculation and tissue oxygenation in human cerebral malaria: a single photon emission computed tomography and near-infrared spectroscopy study. Am J Trop Med Hyg. 1997;56:585–7.PubMedGoogle Scholar
- Looareesuwan S, Wilairatana P, Krishna S, Kendall B, Vannaphan S, Viravan C, et al. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis. 1995;21:300–9.View ArticlePubMedGoogle Scholar
- Beare NAV, Harding SP, Taylor TE, Lewallen S, Molyneux ME. Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis. 2009;199:263–71.PubMed CentralView ArticlePubMedGoogle Scholar
- Maude RJ, Beare NA, Abu Sayeed A, Sayeed A, Chang CC, Charunwatthana P, et al. The spectrum of retinopathy in adults with Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 2009;103:665–71.PubMed CentralView ArticlePubMedGoogle Scholar
- Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, et al. Impaired nitric oxide bioavailability and l-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007;204:2693–704.PubMed CentralView ArticlePubMedGoogle Scholar
- Yeo TW, Lampah DA, Tjitra E, Gitawati R, Kenangalem E, Piera K, et al. Relationship of cell-free haemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis. 2009;200:1522–9.PubMed CentralView ArticlePubMedGoogle Scholar
- Lindegaard K-F, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100:12–24.View ArticleGoogle Scholar
- Newton CR, Marsh K, Peshu N, Kirkham FJ. Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria. Pediatric Neurol. 1996;15:41–9.View ArticleGoogle Scholar
- Clavier N, Rahimy C, Pierre F, Ayivi B, Payen D. No evidence for cerebral hypoperfusion during cerebral malaria. Crit Care Med. 1999;27:628–32.View ArticlePubMedGoogle Scholar
- Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424.PubMed CentralView ArticlePubMedGoogle Scholar
- Hawkes N, Opoka RO, Namasopo S, Miller C, Conroy AL, Serghides L, et al. Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale. Med Hypotheses. 2011;77:437–44.PubMed CentralView ArticlePubMedGoogle Scholar
- Serirom S, Raharjo WH, Chotivanich K, Loareesuwan S, Kubes P, Ho M, et al. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol. 2003;162:1651–60.PubMed CentralView ArticlePubMedGoogle Scholar
- Dondorp AM, Planche T, de Bel EE, Angus BJ, Chotivanich KT, Silamut K, et al. Nitric oxides in plasma, urine, and cerebrospinal fluid in patients with severe falciparum malaria. Am J Trop Med Hyg. 1998;59:497–502.PubMedGoogle Scholar
- Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC, et al. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet. 2003;361:676–8.View ArticlePubMedGoogle Scholar
- Vinchi F, Tolosano E: Therapeutic approaches to limit haemolysis-driven endothelial dysfunction: Scavenging free heme to preserve vasculature homeostasis. Oxid Med Cell Long 2013; 396527.Google Scholar
- Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular haemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–62.View ArticlePubMedGoogle Scholar
- Liu C, Zhao W, Christ GJ, Gladwin MT, Kim-Shapiro DB. Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med. 2013;65:1164–73.View ArticlePubMedGoogle Scholar
- Omodeo-Salè F, Cortelezzi L, Vommaro Z, Scaccabarozzi D, Don-dorp AM. Dysregulation of l-arginine metabolism and bio-availability associated to free plasma heme. Am J Physiol Cell Physiol. 2010;299:148–54.View ArticleGoogle Scholar
- Weinberg JB, Yeo TW, Mukemba JP, Florence SM, Volkheimer AD, Wang H, et al. Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria. J Infect Dis. 2014;210:913–22.PubMed CentralView ArticlePubMedGoogle Scholar
- Wenisch C, Wenisch H, Wilairatana P, Looareesuwan S, Vannaphan S, Wagner O, et al. Big endothelin in patients with complicated Plasmodium falciparum malaria. J Infect Dis. 1996;173:1281–4.View ArticlePubMedGoogle Scholar
- Dietmann A, Lackner P, Helbok R, Spora K, Issifou S, Lell B, Reindl M, et al. Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J. 2008;7:253.PubMed CentralView ArticlePubMedGoogle Scholar
- Basilico N, Parapini S, Sisto F, Omodeo-Salè F, Coghi P, Ravagnani F, et al. The lipid moiety of haemozoin (Malar-ia Pigment) and P. falciparum parasitised red blood cells bind synthetic and native endothelin-1. J Biomed Biotechnol. 2010;210:854927.Google Scholar
- Pongponratn E, Riganti M, Punpoowong B, Aikawa M. Microvas-cular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg. 1991;44:168–75.PubMedGoogle Scholar
- Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, Stepniewska K, et al. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg. 2003;69:345–59.PubMedGoogle Scholar
- Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, Mai NT, et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999;55:395–410.View ArticleGoogle Scholar
- Higgins SJ, Kain KC, Liles WC. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti-Infect Ther. 2011;9:1–17.View ArticleGoogle Scholar
- Van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22:503–8.View ArticlePubMedGoogle Scholar
- Clark IA, Awburn MM, Harper CG, Liomba NG, Molyneux ME. Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis. Malar J. 2003;2:41.PubMed CentralView ArticlePubMedGoogle Scholar
- Clark IA, Awburn MM, Whitten RO, Harper CG, Liomba NG, Molyneux ME, Taylor TE. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar J. 2003;2:6.PubMed CentralView ArticlePubMedGoogle Scholar
- White VA, Lewallen S, Beare NAV, Molyneux ME, Taylor TE. Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One. 2009;4:4317. doi:10.1371/journal.pone.0004317.View ArticleGoogle Scholar
- Barrera V, Hiscott PS, Craig AG, White VA, Milner DA, Beare NA, et al. Severity of retinopathy parallels the degree of parasite sequestration in the eyes and brains of Malawian children with fatal cerebral malaria. J Infect Dis. 2015;211:1977–86.PubMed CentralView ArticlePubMedGoogle Scholar
- Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, et al. Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis. 2012;205:663–71.PubMed CentralView ArticlePubMedGoogle Scholar
- Yeo TW, Lampah DA, Gitawati G, Tjitra E, Kenangalem E, Granger DL, et al. Safety profile of l-arginine infusion in moderately severe falciparum malaria. PLoS One. 2008;3:e2347.PubMed CentralView ArticlePubMedGoogle Scholar
- Yeo TW, Rooslamiati I, Gitawati R, Tjitra E, Lampah DA, Kenangalem E, et al. Pharmacokinetics of l-arginine in adults with moderately severe malaria. Antimicrob Agents Chemother. 2008;52:4381–7.PubMed CentralView ArticlePubMedGoogle Scholar
- Yeo TW, Lampah DA, Rooslamiati I, Gitawati R, Tjitra E, Kenangalem E, et al. A randomized pilot study of l-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics. PLoS One. 2013;8:e69587.PubMed CentralView ArticlePubMedGoogle Scholar
- Ries S, Schminke U, Fassbender K, Daffertshofer M, Steinke W, Hennerici M. Cerebrovascular involvement in the acute phase of bacterial meningitis. J Neurol. 1997;244:51–5.View ArticlePubMedGoogle Scholar
- Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11:906–17.View ArticlePubMedGoogle Scholar
- Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Progr Retin Eye Res. 2001;20:319–49.View ArticleGoogle Scholar
- Brown HC, Chau TT, Mai NT, Day NP, Sinh DX, White NJ, et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 2000;55:104–11.View ArticlePubMedGoogle Scholar
- Warrell DA, Looareesuwan S, Phillips RE, White NJ, Warrell MJ, Chapel HM, et al. Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am J Trop Med Hyg. 1986;35:882–9.PubMedGoogle Scholar
- Bouvry D, Plane’s C, Malbert-Colas L, Escabasse V, Clerici C. Hypoxia-Induced cytoskeleton disruption in alveolar epithelial cells. Am J Resp Cell Mol Biol. 2006;35:519–27.View ArticleGoogle Scholar
- Eisenhut M. Vasospasm in cerebral inflammation. Int J Inflam. 2014;2014:509707.PubMed CentralView ArticlePubMedGoogle Scholar
- Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;3:CD000277.PubMedGoogle Scholar
- Huang RQ, Jiang FG, Feng ZM, Wang TY. Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data. Acta Neurol Belg. 2013;113:3–6.View ArticlePubMedGoogle Scholar
- Guo J, Shi Z, Yang K, Tian JH, Jiang L. Endothelin receptor antagonists for subarachnoid haemorrhage. Cochrane Database Syst Rev. 2012;9:CD008354.PubMedGoogle Scholar
- Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid haemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. J Neurosurg. 2013;119:180–9.View ArticlePubMedGoogle Scholar
- Kramer AH, Fletcher JJ. Locally-administered intra-thecal thrombolytics following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2011;14:489–99.View ArticlePubMedGoogle Scholar
- Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, Gitau E, et al. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci USA. 2008;105:2634–9.PubMed CentralView ArticlePubMedGoogle Scholar
- Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305:239–42.View ArticlePubMedGoogle Scholar
- Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111:171–80.View ArticlePubMedGoogle Scholar
- Suzuki H, Muramatsu M, Kojima T, Taki W. Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid haemorrhage. Stroke. 2003;34:2796–800.View ArticlePubMedGoogle Scholar
- Schaer DJ, Buehler PW, Alayash AI, Belcher JK, Vercellotti GM. Haemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2013;121:1276–84.PubMed CentralView ArticlePubMedGoogle Scholar
- Vinchi F, de Franceschi L, Ghigo A, Townes T, Cimino J, Silengo L, et al. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Circulation. 2013;127:1317–29.View ArticlePubMedGoogle Scholar